Anna Gardin: Incredible Initiative to Measure Clinician’s Own Lp(a) On The Spot at ESOC 2026
Anna Gardin, Neurology Resident at Stroke Unit, “G. Martino” University Hospital, shared on LinkedIn:
”At ESOC 2026, an incredible initiative gave clinicians the chance to measure their own Lp(a) on the spot.
As healthcare professionals, we talk to our patients about cardiovascular risk every day, but how often do we actually look at our own?
Fortunately, my Lp(a) are low (<15 nmol/L).
But this kind of screening is a powerful reminder: elevated Lp(a) can be the nudge we need to double down on the modifiable factors we can control.
And for those with high levels?
The good news is that the therapeutic landscape is evolving.
Novel Lp(a)-lowering agents are on the horizon, and the science is moving fast.
Lead by example. Know your risk.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology